The complement receptor C3AR constitutes a novel therapeutic target in NPM1-mutated AML
- von Palffy, S.
- Thorsson, H.
- Penã-Martínez, P.
- Puente-Moncada, N.
- Sandén, C.
- Blom, A.M.
- Henningsson, R.
- Juliusson, G.
- King, B.
- Landberg, N.
- Lazarevic, V.
- Orsmark-Pietras, C.
- Rissler, M.
- Rissler, V.
- Ågerstam, H.
- Järås, M.
- Lilljebjörn, H.
- Fioretos, T.
ISSN: 2473-9537, 2473-9529
Year of publication: 2023
Volume: 7
Issue: 7
Pages: 1204-1218
Type: Article